Recommendations for the use of botulinum toxin type A in the management of cerebral palsy

This publication has 42 references indexed in Scilit:

• Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
  European Journal of Neurology, 1999
• Interventional Neuropediatrics: Treatment of Dystonic and Spastic Muscular Hyperactivity with Botulinum Toxin A
  Neuropediatrics, 1997
• DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1
  Movement Disorders, 1997
• Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study
  Gait & Posture, 1996
• Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections
  Movement Disorders, 1994
• Botulinum toxin
  Movement Disorders, 1992
• Box and Block Test of Manual Dexterity: Norms for 6–19 Year Olds
  Canadian Journal of Occupational Therapy, 1985
• A Developmental Prehension Assessment for Handicapped Children
  American Journal of Occupational Therapy, 1981
• Local tetanus in cats: The influence of neuromuscular activity on spinal distribution of 125I labelled tetanus toxin
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
• Local tetanus in cats: Neuropharmacokinetics of 125I-tetanus toxin
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973